Global Constipation Treatment Market Size

Constipation Treatment Market Analysis

The constipation treatment market is expected to register a CAGR of nearly 6.9% during the forecast period of 2022-2027.

The onset of the COVID-19 pandemic has led to a reduction in the number of patient visits that reduced the number of patients opting for constipation treatment, thereby impacting the market growth. However, at the onset, SARS-CoV-2 primarily attacks the respiratory system as it represents the main point of entry in the host, but it also can affect multiple organs. According to the study "Impact of COVID-19 on individuals with Irritable Bowel Syndrome and Comorbid Anxiety and/or Depression," published in the Journal of Clinical Gastroenterology in February 2022, individuals who have irritable bowel syndrome and comorbid anxiety and/or depression have more symptoms and a lower quality of life than those who only have Irritable bowel syndrome. As per the study findings, the current COVID-19 pandemic has the potential to exacerbate symptoms in people who have irritable bowel syndrome and also suffer from anxiety or depression. Thus, the COVID-19 outbreak and subsequent symptoms are expected to influence the global constipation treatment market during the forecast period.

The major factor attributing to the growth of the market is the increasing number of geriatric patients. These patients use analgesics such as morphine, hydromorphone, codeine, etc., as a prescription for chronic non-cancer pain, which has severe adverse effects on the digestive system resulting in huge demand for constipation drugs. For instance, according to the Center for Diseases Control and Prevention November 2021, the number of OIC prescriptions increased by 153.3 million in 2019 and 142.8 million in 2020. Thus, the rising volume of patient pool with opioid users demands efficient medication for Opioid-Induced Constipation (OIC) ailments which is likely to fuel the constipation treatment market over the forecast period.

The geriatric population is expected to have a significant impact on the market studied as people aged above 65 are more prone to chronic diseases. Geriatric people are five times more prone than younger adults to experience constipation-related issues. This is caused by poor diet, a lack of sufficient fluids in the diet, a lack of exercise, the use of specific medications to treat other medical disorders, and unfavorable bowel habits are a few causes of this inclination. According to the World Health Organization Facts of 2021, the proportion of the global population aged 60 and up will nearly double from 12% to 22% between 2015 and 2050. Furthermore, according to the World Health Organization, by 2030, 1 out of every 6 people on the planet will be 60 years old or older. The number of people aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. Thus, the growing geriatric population is expected to boost the target market growth over the forecast period. However, increasing dependence on the majority of over-the-counter (OTC) drugs is expected to hamper the target market to a certain extent in the studied period.